Larvol Delta - Beeline-Medicines-formally-launched-Wednesday-with-300-million-in-series-A-financing-and-a-readymade-pipeline-of-immunology-assets-inlicensed-from-Bristol-Myers-Squibb-that-it-hopes-will-help-reshape-how-autoimmune-and-inflammatory-diseases-are-treated

BMS-986498 - Beeline Medicines

BMS-986326 - Beeline Medicines

lomedeucitinib (BMS-986322) - Beeline Medicines

BMS-986481 - Beeline Medicines, BMS

afimetoran (BMS-986256) - Beeline Medicines

https://firstwordpharma.com/story/7181169

Apr 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next